Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: COVID-19 aggravated; This is a spontaneous report from a contactable consumer reporting on behalf of the father and downloaded from the Agency Regulatory Authority-WEB (Regulatory Authority number FR-AFSSAPS-NC20210377). A 94 years old male patient received the first single dose of BNT162B2 (COMIRNATY; lot EJ6788) intramuscular, on 29Jan2021, for COVID-19 immunisation. The patient was resident at the nursing home. Other medical history and concomitant medications were not reported. The anti-COVID vaccine was administered to the patient at the nursing home on 29Jan2021. Following 1 positive case of COVID detected in the nursing home, the residents were confined to their rooms from 30Jan2021. The patient tested positive for COVID on 03Feb2021, as well as 2 other residents of the residence. His state of health quickly deteriorated and he died on 06Feb2021 in the nursing home due to COVID-19 aggravated. It was unknown if an autopsy was done. The pharmacovigilant notes: accountability score(s) established without prejudice to the elements of investigation which could be carried out within the framework of legal or amicable compensation procedures. Official Bulletin of the Minister in charge of Health. No follow-up attempts are possible, no information is expected.; Reported Cause(s) of Death: COVID-19 aggravated
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166